The submission deadline has passed. The page is kept for reference. View active tenders →
Description / Scope of Work
The Nawaz Sharif Institute of Cancer Treatment & Research (NSICT&R) in Lahore, Punjab invites sealed bids under the Single Stage Two Envelope procedure for the framework contract for the procurement of targeted therapies for the fiscal year 2025-26. The tender includes various specialized oncological drugs and pharmaceutical products such as Bicalutamide, Tucatinib, Pazopanib, Abiraterone, and Pegfilgrastim. Eligible manufacturers and authorized distributors registered with the Federal Board of Revenue and appearing on the active taxpayers list must have relevant business experience. Interested firms must submit their technical and financial proposals, along with the required bid security as specified in the bidding documents, to the procurement office no later than 19 May 2026. Bids will be opened publicly on the same day in the presence of attending bidders.